Shamkumar Nambulli
Postdoctoral Fellow (previously held)
Boston University Chobanian & Avedisian School of Medicine

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Reed DS, McElroy AK, Barbeau DJ, McMillen CM, Tilston-Lunel NL, Nambulli S, Cottle E, Gilliland TC, Rannulu H, Lundy J, Olsen EL, O'Malley KJ, Xia M, Hartman AL, Luke TC, Egland K, Bausch C, Wu H, Sullivan EJ, Klimstra WB, Duprex WP. No evidence for enhanced disease with human polyclonal SARS-CoV-2 antibody in the ferret model. PLoS One. 2024; 19(6):e0290909. PMID: 38900732; PMCID: PMC11189238; DOI: 10.1371/journal.pone.0290909;
  2. Nambulli S, Escriou N, Rennick LJ, Demers MJ, Tilston-Lunel NL, McElroy AK, Barbeau DJ, Crossland NA, Hoehl RM, Schrauf S, White AG, Borish HJ, Tomko JA, Frye LJ, Scanga CA, Flynn JL, Martin A, Gerke C, Hartman AL, Duprex WP. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. J Virol. 2024 May 14; 98(5):e0176223.View Related Profiles. PMID: 38563762; PMCID: PMC11092351; DOI: 10.1128/jvi.01762-23;
  3. Guseman AJ, Rennick LJ, Nambulli S, Roy CN, Martinez DR, Yang DT, Bhinderwala F, Vergara S, Schaefer A, Baric RS, Ambrose Z, Duprex WP, Gronenborn AM. Targeting spike glycans to inhibit SARS-CoV2 viral entry. Proc Natl Acad Sci U S A. 2023 Sep 19; 120(38):e2301518120.View Related Profiles. PMID: 37695910; PMCID: PMC10515186; DOI: 10.1073/pnas.2301518120;
  4. Gilliland T, Dunn M, Liu Y, Alcorn MDH, Terada Y, Vasilatos S, Lundy J, Li R, Nambulli S, Larson D, Duprex P, Wu H, Luke T, Bausch C, Egland K, Sullivan E, Wang Z, Klimstra WB. Transchromosomic bovine-derived anti-SARS-CoV-2 polyclonal human antibodies protects hACE2 transgenic hamsters against multiple variants. iScience. 2023 Oct 20; 26(10):107764. PMID: 37736038; PMCID: PMC10509298; DOI: 10.1016/j.isci.2023.107764;
  5. Laksono BM, Roelofs D, Comvalius AD, Schmitz KS, Rijsbergen LC, Geers D, Nambulli S, van Run P, Duprex WP, van den Brand JMA, de Vries RD, de Swart RL. Infection of ferrets with wild type-based recombinant canine distemper virus overwhelms the immune system and causes fatal systemic disease. mSphere. 2023 Aug 24; 8(4):e0008223. PMID: 37377421; PMCID: PMC10449521; DOI: 10.1128/msphere.00082-23;
  6. Roelofs D, Schmitz KS, van Amerongen G, Rijsbergen LC, Laksono BM, Comvalius AD, Nambulli S, Rennick LJ, van Run P, Duprex WP, van den Brand JMA, de Swart RL, de Vries RD. Inoculation of raccoons with a wild-type-based recombinant canine distemper virus results in viremia, lymphopenia, fever, and widespread histological lesions. mSphere. 2023 Aug 24; 8(4):e0014423.View Related Profiles. PMID: 37314205; PMCID: PMC10449507; DOI: 10.1128/msphere.00144-23;
  7. Guseman AJ, Rennick LJ, Nambulli S, Roy CN, Martinez DR, Yang DT, Bhinderwhala F, Vergara S, Baric RS, Ambrose Z, Duprex WP, Gronenborn AM. Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry. bioRxiv. 2022 Dec 22.View Related Profiles. PMID: 36597530; PMCID: PMC9810211; DOI: 10.1101/2022.12.22.521642;
  8. Schrauf S, Tomberger Y, Nambulli S, Duprex WP, Tschismarov R, Tauber E, Ramsauer K. Biodistribution and toxicology evaluation of a recombinant measles Schwarz-based Lassa vaccine in cynomolgus macaques. J Appl Toxicol. 2023 May; 43(5):719-733. PMID: 36480160
  9. Nambulli S, Rennick LJ, Acciardo AS, Tilston-Lunel NL, Ho G, Crossland NA, Hardcastle K, Nieto B, Bainbridge G, Williams T, Sharp CR, Duprex WP. FeMV is a cathepsin-dependent unique morbillivirus infecting the kidneys of domestic cats. Proc Natl Acad Sci U S A. 2022 Oct 25; 119(43):e2209405119.View Related Profiles. PMID: 36251995; PMCID: PMC9618091; DOI: 10.1073/pnas.2209405119;
  10. Xiang Y, Huang W, Liu H, Sang Z, Nambulli S, Tubiana J, Williams KL, Duprex WP, Schneidman-Duhovny D, Wilson IA, Taylor DJ, Shi Y. Superimmunity by pan-sarbecovirus nanobodies. Cell Rep. 2022 Jun 28; 39(13):111004. PMID: 35738279; PMCID: PMC9174178; DOI: 10.1016/j.celrep.2022.111004;
Showing 10 of 30 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 30 publications over 8 distinct years, with a maximum of 8 publications in 2021


Contact for Mentoring:

620 Albany St
Boston MA 02118
Google Map

Nambulli's Networks
Click the "See All" links for more information and interactive visualizations
Similar People